Citrate anticoagulation versus systemic heparinisation in continuous venovenous hemofiltration in critically ill patients with acute kidney injury: a multi-center randomized clinical trial
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1364-8535
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Citrate anticoagulation versus systemic heparinisation in continuous venovenous hemofiltration in critically ill patients with acute kidney injury: a multi-center randomized clinical trial ; volume:18 ; number:4 ; day:16 ; month:8 ; year:2014 ; pages:1-9 ; date:8.2014
Critical care ; 18, Heft 4 (16.8.2014), 1-9, 8.2014
- Urheber
-
Schilder, Louise
- Beteiligte Personen und Organisationen
-
Nurmohamed, S Azam
Bosch, Frank H.
Purmer, Ilse M.
den Boer, Sylvia S.
Kleppe, Cynthia G.
Vervloet, Marc G.
Beishuizen, Albertus
Girbes, Armand RJ
ter Wee, Pieter M.
Groeneveld, AB Johan
SpringerLink (Online service)
- DOI
-
10.1186/s13054-014-0472-6
- URN
-
urn:nbn:de:1111-2016042310515
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:56 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Schilder, Louise
- Nurmohamed, S Azam
- Bosch, Frank H.
- Purmer, Ilse M.
- den Boer, Sylvia S.
- Kleppe, Cynthia G.
- Vervloet, Marc G.
- Beishuizen, Albertus
- Girbes, Armand RJ
- ter Wee, Pieter M.
- Groeneveld, AB Johan
- SpringerLink (Online service)
Ähnliche Objekte (12)
Citrate anticoagulation and systemic heparin anticoagulation during continuous renal replacement therapy among critically-ill children
Flexitrate regional citrate anticoagulation in continuous venovenous hemodiafiltration: a retrospective analysis
Hypercitratemia is a mortality predictor among patients on continuous venovenous hemodiafiltration and regional citrate anticoagulation
Safety and efficacy of regional citrate anticoagulation in continuous venovenous hemodialysis in the presence of liver failure: the Liver Citrate Anticoagulation Threshold (L-CAT) observational study
Low bicarbonate replacement fluid normalizes metabolic alkalosis during continuous veno-venous hemofiltration with regional citrate anticoagulation
Continuous venovenous hemodialysis with regional citrate anticoagulation in patients with liver failure: a prospective observational study
Customized Citrate Anticoagulation versus No Anticoagulant in Continuous Venovenous Hemofiltration in Critically Ill Patients with Acute Kidney Injury: A Prospective Randomized Controlled Trial
Citrate confers less filter-induced complement activation and neutrophil degranulation than heparin when used for anticoagulation during continuous venovenous haemofiltration in critically ill patients
Incidence and outcome of citrate accumulation in critically ill patients undergoing continuous renal replacement therapy with regional citrate anticoagulation
Regional citrate anticoagulation in cardiac surgery patients at high risk of bleeding: a continuous veno-venous hemofiltration protocol with a low concentration citrate solution
Citrate kinetics during regional citrate anticoagulation in extracorporeal organ replacement therapy
Simple citrate anticoagulation protocol for low flux haemodialysis
Citrate anticoagulation and systemic heparin anticoagulation during continuous renal replacement therapy among critically-ill children
Flexitrate regional citrate anticoagulation in continuous venovenous hemodiafiltration: a retrospective analysis
Hypercitratemia is a mortality predictor among patients on continuous venovenous hemodiafiltration and regional citrate anticoagulation
Safety and efficacy of regional citrate anticoagulation in continuous venovenous hemodialysis in the presence of liver failure: the Liver Citrate Anticoagulation Threshold (L-CAT) observational study
Low bicarbonate replacement fluid normalizes metabolic alkalosis during continuous veno-venous hemofiltration with regional citrate anticoagulation
Continuous venovenous hemodialysis with regional citrate anticoagulation in patients with liver failure: a prospective observational study
Customized Citrate Anticoagulation versus No Anticoagulant in Continuous Venovenous Hemofiltration in Critically Ill Patients with Acute Kidney Injury: A Prospective Randomized Controlled Trial
Citrate confers less filter-induced complement activation and neutrophil degranulation than heparin when used for anticoagulation during continuous venovenous haemofiltration in critically ill patients
Incidence and outcome of citrate accumulation in critically ill patients undergoing continuous renal replacement therapy with regional citrate anticoagulation
Regional citrate anticoagulation in cardiac surgery patients at high risk of bleeding: a continuous veno-venous hemofiltration protocol with a low concentration citrate solution
Citrate kinetics during regional citrate anticoagulation in extracorporeal organ replacement therapy
Simple citrate anticoagulation protocol for low flux haemodialysis
Citrate anticoagulation and systemic heparin anticoagulation during continuous renal replacement therapy among critically-ill children
Flexitrate regional citrate anticoagulation in continuous venovenous hemodiafiltration: a retrospective analysis
Hypercitratemia is a mortality predictor among patients on continuous venovenous hemodiafiltration and regional citrate anticoagulation
Safety and efficacy of regional citrate anticoagulation in continuous venovenous hemodialysis in the presence of liver failure: the Liver Citrate Anticoagulation Threshold (L-CAT) observational study
Low bicarbonate replacement fluid normalizes metabolic alkalosis during continuous veno-venous hemofiltration with regional citrate anticoagulation
Continuous venovenous hemodialysis with regional citrate anticoagulation in patients with liver failure: a prospective observational study
Customized Citrate Anticoagulation versus No Anticoagulant in Continuous Venovenous Hemofiltration in Critically Ill Patients with Acute Kidney Injury: A Prospective Randomized Controlled Trial
Citrate confers less filter-induced complement activation and neutrophil degranulation than heparin when used for anticoagulation during continuous venovenous haemofiltration in critically ill patients
Incidence and outcome of citrate accumulation in critically ill patients undergoing continuous renal replacement therapy with regional citrate anticoagulation
Regional citrate anticoagulation in cardiac surgery patients at high risk of bleeding: a continuous veno-venous hemofiltration protocol with a low concentration citrate solution
Citrate kinetics during regional citrate anticoagulation in extracorporeal organ replacement therapy